Cord blood DNA methylation and cell-type composition are not significantly associated with severe preeclampsia after cell-type and clinical covariate adjustment. [PDF]
Yang X +7 more
europepmc +1 more source
Noninvasive Maternal-Fetal Hemodynamic Monitoring as A Predictor of Severe Preeclampsia in Low-Resource Settings: A Case Report. [PDF]
Toledo-Jaldin L +7 more
europepmc +1 more source
Noninvasive blood pressure measurements demonstrated a significant underestimation of blood pressure in a patient with severe preeclampsia: a case report. [PDF]
Zhang Y, Gu J, Yu C.
europepmc +1 more source
Predictors of adverse pregnancy outcomes in severe preeclampsia: A retrospective observational study. [PDF]
Li P, Jiang Y, You Y.
europepmc +1 more source
Intracerebral Hemorrhage: A Fatal Complication of Severe Preeclampsia-A Rare Case Report in a Resource-Limited Setting. [PDF]
Mohamed IA +5 more
europepmc +1 more source
Pathophysiological mechanisms in severe preeclampsia: role of upregulated proteins in blood pressure, extracellular matrix and immunity. [PDF]
Pinto-Souza CC +5 more
europepmc +1 more source
Maternal Cardiac Arrest in Severe Preeclampsia at 34 Weeks: Successful Resuscitation, Perimortem Cesarean Section, and Dual Survival. [PDF]
Deori P +8 more
europepmc +1 more source
Corrigendum: Noninvasive Maternal-Fetal Hemodynamic Monitoring as A Predictor of Severe Preeclampsia in Low-Resource Settings: A Case Report. [PDF]
Toledo-Jaldin L +7 more
europepmc +1 more source
Management of Severe Preeclampsia.
Features of severe preeclampsia include severe proteinuric hypertension and symptoms of central nervous system dysfunction, hepatocellular injury, thrombocytopenia, oliguria, pulmonary oedema, cerebrovascular accident and severe intrauterine growth restriction.
J F Brichant, J F Brichant, P Y Dewandre
exaly +5 more sources

